Get your company’s press releases published in the world’s most powerful biotechnology publication.
GEN’s editorial strength lies in the wide breadth of coverage encompassing the entire field of biotechnology, from the latest advances in drug discovery through bioprocess scale-up and commercial production. Biotechnology professionals rely on GEN for authoritative coverage of genomics, proteomics, epigenomics, sequencing, PCR, biomarker discovery, molecular diagnostics, bioprocessing, and more.
GEN welcomes your news and new product releases. We also invite companies to submit tutorials and application notes as well as technology overview articles that serve to demonstrate your firm’s expertise and bring you new business opportunities.
Please see GEN’s guidelines below for submitting news, articles, tutorials, and new product information.
Print and Online News
Send all press releases to Tamlyn Oliver at firstname.lastname@example.org.
News is compiled daily for GEN’s online news coverage. The stories are posted each day on our website and distributed in an e-newsletter to subscribers.
News Columns in Print GEN
Reports on scale-up and production: purification, cell culture, facility news, CMO agreements, and more.
Reviews deals and findings involving biotech and pharma companies: biomarker discoveries, licensing transactions, M&A activity, collaborations for R&D, commercialization, etc.
Includes Phase I through III studies in various indications.
Discovery & Development
Covers the gamut of alliances formed related to preclinical and clinical R&D: target identification, validation, IND-enabling studies, and more.
Genomics & Proteomics
Details research and partnerships: gene identification and manipulation, gene and protein expression, protein-structure analysis, etc.
Analyzes business and financial news: M&A activity, divestitures, establishment of subsidiaries, regulatory approvals, grants and funding, and more.
Products & Services
Looks at agreements among biotech, pharmaceutical, and supplier companies: technology transfer, enabling technology deals, CRO transactions, etc.
People in the News
Lists new hires and promotions in the industry
Additional columns include: Point of View (opinions on a biotech-related issue), Legal Affairs (authored by lawyers with biotech expertise), Corporate Profiles (company profiles), Wall Street Biobeat (GEN’s monthly financial-themed column), and Biomarket Trends (industry trends summarized from specialist reports). Submission queries for these columns should be directed to Tamlyn Oliver at email@example.com. Finally, GEN’s Calendar of Events includes conferences, trade shows, workshops, and symposia relevant to biotech. Send calendar items to Sunya Bhutta at firstname.lastname@example.org.
New Product Announcements
GEN offers biotechnology tool providers a compelling way to promote their new products. All new product announcements should be sent to Patrice Bartell at email@example.com. Please send a full product description, company name, website, and product shot with a resolution of 300 dpi at 5-inches wide. Submission of the high-resolution electronic image of the product is mandatory. Logos are not accepted. Additionally, a product-specific video can be posted along with a new product announcement on GEN’s website for a fee of $995. Videos must be submitted in web-ready flash format.
GEN’s editorial calendar lists the feature articles for each issue. If you want your company included in a particular article, please contact John Sterling at firstname.lastname@example.org three months prior to the publication date (clearly indicating the issue and topic in the subject line of your email message), as this is generally when articles are assigned.
GEN publishes Drug Discovery, Assay, Bioprocess, and Translational Medicine Tutorials in every issue. We welcome queries for submissions of tutorials outlining the use of a particular technology or application. These semi-technical articles should preferably include numerical and/or pictographic data (three graphics maximum, including tables). Please avoid marketing descriptions or advertorial writing; it is GEN’s policy to focus on the science. This is an opportunity to highlight the technical strengths of your company’s product or service. Note that we do not include references; tutorials are technical application notes and not data-rigorous presentations such as peer-reviewed submissions.
As tutorials are not usually time-sensitive, GEN schedules these articles many months in advance. You may wish to time the publication of your tutorial with a particular issue given its editorial focus or its intended distribution. If so, please query us well in advance to ensure that a particular slot is available. As space varies, however, inclusion in a particular issue cannot be guaranteed.
Please contact John Sterling (email@example.com) or Tamlyn Oliver (firstname.lastname@example.org) to pitch a tutorial idea. If your tutorial query is accepted, we will contact you with detailed submission requirements and guidelines for submitting electronic graphics. GEN is now accepting video submissions to accompany tutorials. Cost for videos is $995. Videos must be submitted in web-ready flash format.
Drug Discovery Tutorials cover technology related to high-throughput screening, target identification, validation, etc., that is used to identify and develop biopharmaceutical compounds and small molecules. Word count: 1,000–1,200 words.
Assay Tutorials cover technology relating to assays for drug discovery and development. Word count: 1,000–1,200 words.
Bioprocess Tutorials cover technology, from bioreactors to media to cell lines, relating to cell culture, scale-up, process transfer, etc. Word count: 1,000–1,200 words.
Translational Medicine Tutorials cover clinical research and technology and methods for the manufacture and production of molecular diagnostic products. Word count: 1,000–1,200 words.
*Note that GEN does not solicit payment for any editorial coverage and respects all embargoes.
GEN’s Planning Calendar containing the editorial focus for each issue
GEN distributes particular issues at international meetings and conferences. These are also listed in the editorial calendar.
GEN Contact Information
Editorial Office: (914) 740-2200
Editor in Chief—John Sterling (email@example.com)
Managing Editor—Tamlyn Oliver (firstname.lastname@example.org)